Image

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

Recruiting
18-75 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The study is a single center, open, prospective, self controlled clinical study. The patients with diabetes who are to be enrolled in peritoneal dialysis are to observe the changes of glycosylated hemoglobin relative to the baseline 90 days after using amino acid (15) peritoneal dialysis solution.

Eligibility

Inclusion Criteria: * Type I or II diabetes patients aged 18 to 75 years (including 18 and 75 years), regardless of gender; * Stable peritoneal dialysis patients who have undergone peritoneal dialysis treatment for ≥ 3 months; * Use 3-5 bags of peritoneal dialysis solution daily; * 6.0%\38 mmol/l; 3. Metabolic acidosis (CO2 binding capacity\<22mmol/L); 4. Severe hypokalemia (blood potassium\<2.5mmol/L); 5. Various congenital amino acid metabolism abnormalities; 6. Liver dysfunction (alanine aminotransferase levels exceeding 2.5 times the upper limit of normal); * Combined hemoglobinopathies: such as thalassemia, sickle cell disease, etc; * It is expected that kidney transplantation may be accepted during the trial period; * Participated in other clinical studies.

Study details
    Peritoneal Dialysis
    Diabetes

NCT07077538

The People's Hospital of Gaozhou

14 May 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.